Skip to main content
XXII
NASDAQ Life Sciences

22nd Century Group Secures $9.5M Non-Dilutive Settlement, Becomes Debt-Free

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Healthcare
Sentiment info
Positive
Importance info
9
Price
$3.43
Mkt Cap
$1.678M
52W Low
$3.29
52W High
$841.8
52W Position info
4.3% above low
Off High info
100% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

XXII is trading near its 52-week low of $3.29 (4.3% above the low).

Summary

22nd Century Group reported its fourth quarter and full year 2025 financial results, showing a slight decrease in net revenues to $3.5 million but significant improvements in profitability metrics, with gross, operating, and net losses all decreasing. Most notably, the company announced it has become debt-free and secured a substantial $9.5 million non-dilutive insurance settlement related to a 2022 facility fire. This settlement is exceptionally material for a company with a market capitalization of approximately $1.68 million, providing a significant capital injection without further shareholder dilution. This news follows recent SEC filings (March 20 and 24) detailing a $20 million registered direct offering, making the improved financial health and non-dilutive capital even more critical. The strengthened balance sheet and reduced cost base are expected to support the company's strategic pivot towards higher-margin branded products and expansion of its VLN® offerings. Traders will be watching for continued progress on VLN® distribution and the path to sustained profitability.

At the time of this announcement, XXII was trading at $3.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7M. The 52-week trading range was $3.29 to $841.80. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

XXII - Latest Insights

XXII
Sep 28, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.39
Real-time Price: $0.890 info
Change: -$0.4975 (-36%) info
Market Cap: $652.591K info
XXII
Aug 14, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.33
Real-time Price: $0.890 info
Change: -$3.44 (-79%) info
Market Cap: $652.591K info
XXII
Aug 14, 2026, 4:13 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $4.33
Real-time Price: $0.890 info
Change: -$3.44 (-79%) info
Market Cap: $652.591K info
XXII
Aug 13, 2026, 6:14 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $4.19
Real-time Price: $0.890 info
Change: -$3.30 (-79%) info
Market Cap: $652.591K info
XXII
Aug 13, 2026, 6:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.19
Real-time Price: $0.890 info
Change: -$3.30 (-79%) info
Market Cap: $652.591K info